ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1188

Development of a Method to Isolate Functional Mitochondria and Assess Their Functionality and Integration in Joint Tissues: In Vitro and in Vivo Models

Mercedes Fernandez-Moreno1, Tamara Hermida-Gomez2, Sara Paniagua-Barro1, Arianna Rodriguez-Coello1, Carlos Vaamonde-garcia1 and Francisco J. Blanco3, 1Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Spain; Universidade de A Coruña (UDC), A Coruña, Spain; Grupo de Investigación en Reumatología y Salud (GIR-S), Departamento de Biologia, Facultad de Ciencias. Centro Interdisciplinar de Química y Biología (CICA), INIBIC-Sergas, Universidade de A Coruña (UDC), A Coruña, Spain, 22) Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). Centro interdisciplinar de química e bioloxia (CICA). As Xubias, 15006. A Coruña, España. 3) Centro de investigación biomédica en Red, Bioingenieria, Biomatereial y Nanomedicina (CIBER-BBN), A Coruña, Spain, 3Rheumatology department, Complexo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC), A Coruña, Spain

Meeting: ACR Convergence 2023

Keywords: Mitochondrial Dysfunction, Osteoarthritis, Therapy, alternative

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1183–1199) Osteoarthritis – Clinical Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: There is not cure or an efficient treatment for the osteoarthritis (OA). Mitochondrial damage and dysfunction are described during OA process modulating chondrocyte function and survival contributing to its pathogenesis. As a consequence, mitochondria has proposed as a potential therapeutic target for OA.

Aim: To describe a method to isolate functional mitochondria and assess their functionality and capacity to integrate in joint tissues

Methods: Magnetic beads coupled to anti-TOM22 was used to obtain isolate mitochondria from liver of C57BL/6JOlaHsd after classical tissue digestion. Transmission Electron microscopy (TEM) images and Western blot (WB) were using to stablish the purity and the analysis of Mitotracker Red® staining and ATP were studied in the stablish of mitochondria viability. To evaluated the capacity of mitochondria to integrated in the joint tissues, cartilage and synovial membrane explants were co-incubated in presence of isolated mitochondria labeled with Iron nanoparticles or MitoTarker Red ® during 24, 48 hours (h).Mitochondria labeled with Mitotracker Red® were injected in left knee of 3 C57BL/6JOlaHsd mice and 48 h after the animals were euthanized. The ability of the injected mitochondria to cross the different joint tissues was analyzed, as well as the biological effect and safety of the intra-articular injection.

Results: Normal mitochondrial morphology was obtained when TEM images were analyzed (Figure 1-A). WB showed a big signal of ATP synthase α in mitochondrial isolated fraction while BIP and Tubulin-α were detected only in the elution fraction (Figure 1-B). These data reflected that isolated mitochondria were purity. The Mitochondria viability was analyzed through the evaluation of MitoTracker Red ® fluorescence and ATP production. Isolated mitochondria labeled with MitoTracker Red ® showed higher fluorescent than the same samples without label (81±6.92 vs 2.51±0.29, p=0.05) (Figure 1-C). ATP production in isolated mitochondria was modulated when were incubated in presence of 0.8 µM Rotenone (27.64±3.42 vs 16.76±4.62) (Figure 1-D). These results showed that isolated mitochondria were functional.

In vitro analysis showed the presence of isolated mitochondria embedded in the ECM of the superficial and intermedial layer of cartilage and into the ECM of synovial tissue (Figure 2-A-B). Morphology of chondrocytes in the different layers of the cartilage and morphology of synoviocytes did not show any change. Intrarticular injection of mitochondria caused low grade of joint inflammatory response as well as any systemic complication, no animal dead. Histologic studies of left joint showed Mitotracker Red® signal in the synovial membrane and in the superficial layer of the cartilage (Figure 2-C). Synovitis was not present. Histologic studies of the right knee and organs did not detect any red fluorescence stain.

Conclusion: Isolated mitochondria penetrate ECM of cartilage and synovium. In mice, intraarticular injection of functional isolated mitochondria is safety. These data give us the opportunity to continue studying the mitochondria as a treatment for OA.

Supporting image 1

Supporting image 2


Disclosures: M. Fernandez-Moreno: None; T. Hermida-Gomez: None; S. Paniagua-Barro: None; A. Rodriguez-Coello: None; C. Vaamonde-garcia: None; F. Blanco: None.

To cite this abstract in AMA style:

Fernandez-Moreno M, Hermida-Gomez T, Paniagua-Barro S, Rodriguez-Coello A, Vaamonde-garcia C, Blanco F. Development of a Method to Isolate Functional Mitochondria and Assess Their Functionality and Integration in Joint Tissues: In Vitro and in Vivo Models [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/development-of-a-method-to-isolate-functional-mitochondria-and-assess-their-functionality-and-integration-in-joint-tissues-in-vitro-and-in-vivo-models/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-method-to-isolate-functional-mitochondria-and-assess-their-functionality-and-integration-in-joint-tissues-in-vitro-and-in-vivo-models/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology